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Abstract 
Purpose: Calcium supplements, typically calcium carbonate based, are prescribed for postmenopausal women as 
an aid to prevent osteoporotic fractures. Recent literature suggests these calcium carbonate based supplements in 
addition to having a low bioavailability, can have adverse side effects including increased risk of heart attack. 
This study used a calcium–rich, marine multi-mineral complex (Aquamin) in an ovariectomised rat model of 
osteoporosis to demonstrate its efficacy in comparison to calcium carbonate.  
Methods: Animals were randomly assigned to either non-ovariectomy control (Control), ovariectomy plus 
calcium carbonate (OVX), ovariectomy plus Aqaumin (Aquamin) or ovariectomy plus Aquamin delay where 
treatment started at week 8 (Aquamin delay). At the end of the twenty week study, the trabecular architecture 
was measured using micro computed tomography, composition was assessed using Fourier transform infrared 
spectroscopy and the mechanical properties were determined using nanoindentation and three point bend testing.  
Results: The study demonstrates that oral ingestion of Aquamin has the ability to preserve trabecular bone 
structure, mineral composition, tissue level biomechanical properties and whole bone strength in the proximal 
tibia of rats following ovariectomy better than calcium carbonate.  
Conclusion: This study supports the use of Aquamin as a supplement to aid in the prevention of bone loss in 
post-menopausal women.  
 
Mini-Abstract  
Calcium carbonate supplements are prescribed to prevent osteoporotic fractures. However, they are linked to 
increased risk of heart attack. We examined a marine source of calcium, Aquamin, and determined that it 
preserved bone structure better than calcium carbonate. Aquamin could be used in the prevention of bone loss in 
post-menopausal women. 
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Introduction 
Osteoporosis is a disease that degrades bone mass and architecture, and impairs the ability of the skeleton to 
perform fundamental mechanical functions. Physiologically, osteoporosis occurs due to an imbalance in bone 
cell activity by which excessive resorption occurs without adequate new bone formation, thereby reducing total 
bone mass. As a consequence,  bone  strength  is  reduced  and  typically  fractures  of  the vertebrae, hip or 
wrist occur potentially leading to deformity, severe pain and in some cases death. Osteoporosis causes more 
than 8.9 million fractures annually worldwide, or one every three seconds, approximately half of which occur in 
Europe, corresponding with one fracture every 8 seconds [1]. These 4 million osteoporotic fractures are 
estimated to cost the EU in the region of €31.7 billion, a figure which is expected to increase to €76.7 billion in 
2050 based on the anticipated changes in the demography of Europe [2]. 
Calcium is a main constituent of the hydroxyapatite mineral which provides mechanical strength to the skeleton. 
In addition to the skeletons’ roles of providing support, protection and enabling movement, it also acts as a 
calcium reserve for the body. Therefore, when calcium levels elsewhere in the body are low, this triggers the 
parathyroid hormone (PTH) to release calcium from bone by stimulating bone breakdown [3]. To prevent this 
from occurring, many pre- and post-menopausal women are prescribed calcium supplements in a bid to avert 
bone loss and prevent a fracture from occurring [4,5].  The majority of these calcium supplements are calcium 
carbonate based,  and have been linked to myocardial infarction, angina, transient ischaemic attack or stroke 
[6,7]. A study published in the British Medical Journal stated that a reassessment of the role of calcium 
supplements in the management of osteoporosis was warranted [8]. 
Aquamin is a natural, calcium-rich marine multi-mineral complex food supplement which is derived from the 
calcified skeletal remains of the red marine algae species Lithothamnion, found off the coast of Ireland and 
Iceland. It is available commercially in a number of forms, which have calcium concentrations ranging up to 31 
weight percent (wt %). In addition to calcium, Aquamin also contains 73 other trace minerals including 
magnesium, strontium, manganese, selenium, copper and zinc, which have been identified as important in bone 
health [9].  Minerals from sea-water accumulate in the fronds of the algae during their lifetime, until eventually 
the fronds break off and the calcified remains are harvested and processed. The supplement does not contain any 
additives; the mineralised fronds are simply sterilised, dried and milled to produce the Aquamin supplements. 
Unlike calcium carbonate, which is extracted from limestone or rock and is made up entirely of calcite, 
Aquamin is crafted naturally in the sea, providing a unique porous honeycombed vegetative cell structure with 
argonite, vaterite and calcite calcium salts present. This structure not only gives a number of significant benefits 
in its chemical behaviour and its absorption, it also lowers serum lipid levels, a precursor to many 
cardiovascular events, in postmenopausal women [10]. 
A number of recent trials have also identified several positive effects of Aquamin on bone health. Two double-
blind, placebo-controlled studies measured the bioavailability of Aquamin versus calcium carbonate. These 
studies found that as early as 60 minutes following treatment, PTH levels were significantly reduced in the 
Aquamin group compared to calcium carbonate and placebo groups. In-vitro studies on osteoblast cells cultured 
in the presence of Aquamin exhibited early osteogenic potential and produced more mineral than those cultured 
in its absence [11-13]. An in-vivo study in which Aquamin was used as a dietary supplement in mice on a high-
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fat Western diet (HFWD) showed that bone structure and function were preserved [14]. Indeed, the bone 
structure of these mice was superior to that of mice on the standard low-fat diet, thus asserting the osteogenic 
effect of Aquamin on bone cells. In a study conducted in yearling horses, Aquamin’s influence on bone turnover 
was measured and found to be increased, suggesting that old or damaged bone could be replaced or removed 
which could, in turn, reduce incidents of clinical bone injury [15]. These results indicate that Aquamin has the 
potential to act as a supplement to enhance bone formation.  
Using an established model of osteoporotic bone loss, the purpose of this study was to determine whether 
Aquamin has the potential to prevent bone loss and function. A secondary aim was to assess Aquamin’s ability 
to restore bone following significant loss. Specifically bone structure, composition and mechanical properties 
were assessed in ovarectomised rats and those treated with Aquamin.  
Methods 
Animals 
Eighty-eight female, retired breeder Wistar rats, both ovariectomised and age matched controls, were obtained 
from Harlan Laboratories (UK) and allowed to acclimatize for 5 days before the start of the experiment (Week 
0). The rats were maintained with a cycle of 12 hours light and 12 hours darkness. The experiment was 
approved by the Animal Ethics Committee of Trinity College Dublin, Ireland and performed under licence 
issued by the Department of Health. All applicable institutional and national guidelines for the care and use of 
animals were followed. Two diets were used in this study, a regular murine chow (RM1) and a specially 
formulated RM1 supplemented with Aquamin (both from Special Diet Services, UK). For the supplemented 
feed, calcium (in the form of calcium carbonate) was removed from RM1 and Aquamin (31 wt% calcium) was 
added at a concentration such that calcium levels were equal in both feeds. The rats were divided into four 
groups: (1) control (n=28; RM1), (2) OVX (n=24, RM1), (3) OVX plus Aquamin (n=24, supplemented RM1) 
and (4) OVX plus Aquamin delay (n=12; RM1 for 8 weeks followed by supplemented RM1). Rats were 
ovariectomized one week prior to week 0, during the acclimatisation period all animals were fed RM1. At week 
0, Aquamin treatment was started in group 3 while group 4 treatment started at week 8. Animals were allowed 
to eat and drink ad libitum and routinely weighed before being euthanized at weeks 0, 2, 8, 12 and 20.  
Micro Computed Tomography (MicroCT) (Structure and composition) 
Following sacrifice, the left tibia was removed for microCT scanning (µCT40, Scanco, Switzerland) at two 
locations. The midpoint of the tibia was identified and 10% of the tibial length was scanned around this position. 
From the diaphyseal scans, the hydroxyapatite (HA) content was determined. The metaphyseal trabecular region 
of the proximal tibia immediately below the epiphyseal growth plate was selected and 100 adjacent slices were 
scanned.  From these scans, the trabecular bone was manually selected and bone structural parameters of bone 
volume fraction (BV/TV), trabecular number (Tb.N), trabecular thickness (Tb.Th), trabecular separation (Tb.Sp) 
and the hydroxyapatite content were automatically determined using Scanco software. Microarchitecture was 
analyzed at a resolution of 8µm, at 70kVp and 114µA and a threshold value of 210.   
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Fourier Transform Infrared Spectroscopy (FTIR) (Composition) 
One-hundred micron thick samples were sectioned from the distal tibia using a diamond saw (Minitom, Struers, 
Denmark). As water has a strong absorbance in the infrared, tissues are dehydrated before analyses, thus the 
water spectrum is not observed. The dehydrated samples were placed on a calcium fluoride slide and positioned 
on the microscope stage of the Spotlight 400 FTIR Imaging system (Perkin Elmer). The system is equipped with 
an AutoImage microscope system operating with a 40X Cassegrain objective. A visible white-light image was 
recorded of the sample and the area to be scanned using infra-red was specified. FTIR images were acquired in 
attenuated total reflectance (ATR) imaging mode. The data were collected over the nominal free-scanning 
spectral range, 4000 – 600 cm-1. Spectral measurements were acquired with a pixel size of 6.25 μm x 6.25 μm at 
a spectral resolution of 4 cm
-1
. Background measurements were acquired on a region with 
no tissue with 120 scans per pixel, whereas 32 scans per pixel were recorded from the sample.  
Nanoindentation Material Test (Mechanical properties) 
Two-hundred micron thick samples were sectioned from the distal tibia (adjacent to the FTIR samples) using a 
diamond saw (Minitom, Struers, Denmark) before being polished with a series of graded silica-carbide grinding 
sheets. A Nano indenter XP system (MTS System Corporation, Oak Ridge, TN) was used to measure tissue 
level mechanical properties of proximal tibia sections. The Young’s modulus (E) and contact hardness (Hc) were 
assessed using an AccuTip™ diamond  Berkovich  indenter tip with defined elastic modulus of 1141GPa, a 
Poisson’s ratio equal to 0.07 and a radius of <50 nm. A total of twenty indents were performed on each sample: 
10 evenly spaced indents in the cortical shell and a further 10 indents in the trabecular bone, five in an outer ring 
and five in an inner ring at the centre of the sample. A permanent hardness impression was made by driving the 
indenter into the sample for 90 s to a maximum load of 20 mN, holding for 120 s and then unloading. This cycle 
was repeated 3 times at each location and the modulus was determined from the unloading segment of the final 
indent [16]. 
Three-Point Bend Test (Mechanical properties) 
Following microCT, a standard three-point bending test was applied to the tibia. The tibiae were placed on the 
lateral surface on two rounded supporting bars with a distance of 12 mm between them. A preload of 1 N was 
applied (Z020; Zwick, Ulm, Germany) at the medial surface of the diaphysis by lowering a third rounded bar. A 
constant displacement rate of 5 mm/minute was applied until failure. Displacement was measured from the 
actuator displacement transducer of the testing machine. Maximum load, maximum displacement and stiffness 
were calculated for each sample.  
Statistics  
All results are presented in graphs as the mean ± standard deviation. For statistical analyses, results were tested 
for normality with the Shapiro-Wilk test and outliers were identified using P-P plots and scatter plots. The 
analysis was carried out using the SPSS software package (SPSS Inc., Chicago, IL). One-way ANOVA and the 
Mann-Whitney rank sum tests were used to determine statistical significance. A difference of p ≤ 0.05 was 
considered significant. 
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Results 
Structure 
Three-dimensional and two-dimensional representative samples from each of the groups are shown in Figure 1. 
These slices and reconstructions show an intact and well-connected trabecular microstructure in the control 
samples. A significant loss of trabecular bone structure following 20 weeks of ovariectomy is evident in the 
centre of the OVX samples. The trabecular structure is preserved when Aquamin administration is begun at 
week 0. The Aquamin delay group has a structure which appears intermediate between the OVX and OVX+ 
Aquamin group.  
Qualitative analysis shows that as early as week 2, the ovariectomized group displayed large changes in 
structural parameters indicating the development of osteopenia (Figure 2). Significant losses in bone volume 
fraction (BV/TV) were observed in the OVX group at week 8 following a strong trend at week 2 (p = 0.07). 
Similarly trabecular separation (Tb.Sp) was significantly increased in the OVX group by week 12 while 
trabecular number (Tb.N) was significantly reduced in the OVX group by week 20. No significant changes were 
measured in trabecular thickness (Tr.Th) between groups over the study period. 
Treatment with Aquamin resulted in a significant preservation of bone volume fraction by week 20 relative to 
the OVX group. Although not significant, strong trends were evident by week 20 between OVX and the 
Aquamin treated group with respect to Tr.N (p = 0.1) and Tr.Sp (p = 0.1). The Aquamin delay treatment group 
showed strong trends although no significant improvement in trabecular architecture was measured following 8 
weeks of normal chow and a subsequent 12 week Aquamin treatment.  
Composition: Hydroxyapatite content  
Hydroxyapatite content measured using microCT indicated a significant reduction in the HA content of both 
trabecular and cortical bone by week 20 as seen in Figure 3. Beginning oral administration of Aquamin at week 
0 prevented this loss in both trabecular and cortical bone. Beginning administration of Aquamin 8 weeks 
following ovariectomy was also sufficient to prevent a significant loss of mineral content from trabecular bone. 
Qualitative FTIR 
In Figure 4a, the week 20 representative control sample visualised with white light (centre panel) shows bone 
with a healthy micro architecture and good trabecular interconnectivity. The ATR spectrum which is recorded 
can be represented as an absorbance spectrum. The same region of bone visualised as an absorbance heat map 
(left hand panel) displays an abundance of red/orange indicating increased absorption on the surface of the 
sample. In ATR mode (right hand panel), blue/purple indicates increased reflection at the surface. Visual 
inspection of the white light and infrared maps for the OVX sample shows significant microarchitecture 
deterioration and less absorption and reflection than in the control group. Treatment with Aquamin shows 
increased absorbance represented by the increased presence of red in absorbance and purple/blue in the ATR 
heat maps. The Aquamin delay group displays absorbance and reflection profiles which are intermediate to the 
OVX and the Aquamin groups as indicated by red and green in the absorbance and purple and green in the ATR 
maps. 
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Quantitative FTIR  
The infrared spectrum of bone shows the presence of the major molecular species, phosphate (from the mineral 
hydroxyapatite), carbonate (from carbonate substitution for hydroxyl and phosphate groups), and amide I, II, 
and III from the protein constituents of bone (mainly type I collagen) [17]. These peaks are shown in a 
representative spectrum from a healthy control sample in Figure 4b. The mineral/matrix ratio is linearly related 
to the mineral content and the carbonate/phosphate ratio is related to the chemically measured 
carbonate/phosphate content. In the trabecular region from each absorbance spectrum, the mineral-to-matrix 
ratio was assessed as the ratio of the area of the phosphate band (1170 - 980 cm
-1
) to the area of the amide I 
band (1712 - 1592 cm
-1
). The carbonate/phosphate ratio was assessed as the ratio of the area of the phosphate 
band to the area of the carbonate band (890-840 cm
-1
) [17]. Analysis of the ATR spectra (Figure 4c) indicates a 
significant reduction in the mineral/matrix ratio in the OVX group relative to the control group at week 20. This 
reduction of mineral/matrix ratio was prevented by starting Aquamin administration at week 0. The late 
administration of Aquamin did not significantly prevent the change in mineral/matrix ratio. No significant 
changes were measured in the carbonate/phosphate ratio between groups (Figure 4d). 
Biomechanical Properties 
Nanoindentation Material Test 
The Young’s modulus and hardness data are presented in Table 1. In the control group, the value of the Young’s 
modulus is lowest in the cortical shell, increasing significantly in trabeculae near the edge of this cortical shell 
and increasing again in trabeculae at the core of the sample. A similar pattern is seen for the hardness. In the 
OVX group, this stepwise increase disappears and there is only a significant difference between the core 
trabeculae and the edge/cortical shell when the modulus is assessed and there are no differences between 
locations when hardness is analysed. In the OVX + Aquamin group, trabecular bone moduli and hardness values 
are significantly greater than the cortical shell values. No significant differences were measured in the OVX + 
Aquamin delay group.  
Analysis between groups in trabecular bone from the core found the modulus for the control group to be 
significantly higher than the OVX and the OVX + Aquamin delay groups. The OVX + Aquamin group was not 
significantly different from the control group although it was trending higher than the OVX group. Similar 
results were observed for hardness. For trabeculae located around the edge of the sample, both the modulus and 
hardness in the OVX + Aquamin group was significantly greater than that for the OVX group. For cortical bone, 
both moduli and hardness in the OVX + Aquamin delay group were significantly higher than measured in the 
control group. Hardness in cortical bone from the OVX + Aquamin group was also higher than the control 
group.  
Three-Point Bend Test 
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Analysis of the cortical shell by three point bend test found a significant reduction in the maximum load 
sustained by the OVX group between week 2 and week 20 (Table 4). No significant differences were measured 
in maximum displacement between any of the groups or over the study duration. A significant increase in 
stiffness was measured in the OVX + Aquamin group compared to OVX at week 20.  
 
Discussion 
In this study we examined the effects of ovariectomy and a natural, calcium-rich marine multi-mineral complex 
on bone structure, composition and strength in a rat model of osteoporosis. The results of the study indicate that 
Aquamin has the potential to prevent the loss of trabecular bone in the proximal tibia of ovariectomised rats 
following 20 weeks of treatment. This protection of structure was accompanied by a preservation of the mineral 
composition and follows through to maintaining the mechanical integrity. Analysis of the samples from animals 
subject to the delayed Aquamin treatment was inconclusive for a number of reasons which are discussed in 
further detail in this discussion. The use of a non-ovariectomy control fed group proved the efficacy of our 
model as significant losses in bone volume were observed and measured in the ovariectomy group as early as 8 
weeks when compared to the non-ovariectomy control. This loss of structure was accompanied by a degradation 
in the composition and mechanical properties of the remaining bone, typical characteristics of osteoporosis.   
In the current study, both the regular chow (RM1) and the Aquamin supplemented chow have equal amounts of 
calcium. Therefore, the Aquamin treated animals did not receive extra dietary calcium. The significant 
inhibition of bone loss, measured by week 20 in this study, is therefore not a result of the quantity of calcium 
ingested. The significant preservation of the trabecular structure in the Aquamin groups is most likely brought 
about by the unique form in which the calcium is supplied by Aquamin. Since calcium’s role in the prevention 
of osteoporosis in humans was proven some 30 years ago, its bioavailability has been the subject of numerous 
scientific studies. Calcium carbonate is typically used as the calcium supplement of choice worldwide, however, 
it is known that its bioavailability is very low, only around 20–30% [18]. The form of dietary calcium is a 
critical factor in determining the availability of calcium for bone development and maintenance. The structure of 
the calcium salts in Aquamin dramatically increase the calcium surface area, thus stomach acid can come into 
greater contact with the calcium making it easy to dissolve into the body and providing greater efficacy. 
Additionally, calcium carbonate is not easily absorbed as the phosphorus binds tightly to the calcium.   
This difference in bioavailability is one of the factors postulated to explain the positive Aquamin results 
observed in this study. In addition to calcium, Aquamin also contains 73 additional minerals many of which 
have a proven osteogenic potential through direct or indirect effects on bone cells or bone mineral and collagen. 
Magnesium is a major component of Aquamin, it is essential for all living cells, including osteoblasts and 
osteoclasts, as it is fundamental in adenosine triphosphate [19]. However, its role in bone is not confined to 
simply cell biology, a dietary magnesium restriction has been shown to promote osteoporosis [20]. Potassium is 
critical for calcium metabolism in many enzymes and potassium is also required for improved bone strength and 
density [21]. Copper plays a role in collagen crosslinking and fixing calcium within bones [22]. Some elements, 
such as strontium, are chemically similar to calcium. Strontium has an anabolic activity in bone, and this may 
have significant beneficial effects on bone balance in normal and osteopenic animals [23]. The osteogenic effect 
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offered by these elements in combination with a readily available calcium source will likely have a synergistic 
effect. It is also recognised that calcium bioavailability is influenced and enhanced by the presence of other 
minerals [24]. Aquamin also contains a unique trace mineral profile gained from its marine source. Alone, these 
elements may be insignificant, but within a multi-mineral matrix they work synergistically and may give a 
powerful boost to the action of the calcium.  
Starting oral administration of Aquamin immediately following ovariectomy demonstrated the capacity to 
prevent trabecular bone loss in the proximal tibia of rats associated with ovariectomy. Although only bone 
volume fraction was significantly altered by Aquamin, it is important to note that trabecular number, separation 
and thickness are all incorporated into the software calculation of the trabecular bone volume fraction. 
Therefore, while individually these parameters were unchanged, collectively they resulted in the overall 
reduction in bone loss which can be seen visually in the microCT 2-dimensional slices and the 3-dimensional 
reconstructions. It is important to note that Aquamin is a neutraceutical and is not as potent as pharmaceuticals. 
Therefore, to achieve a significant preservation of trabecular architecture after only 20 weeks by simply 
substituting calcium carbonate for Aquamin is a major outcome.   
Bone is a composite material consisting of a mineral phase (hydroxyapatite), collagen, non-collagenous 
proteins, lipids, and water [25]. Fourier transform infrared spectroscopy can show the presence of the major 
molecular species, phosphate (from the mineral hydroxyapatite), carbonate (from carbonate substitution for 
hydroxyl and phosphate groups), and amide I, II, and III from the protein constituents of bone (mainly type I 
collagen). In the current study there was a significant reduction in the mineral-matrix ratio measured in 
trabecular bone from the ovariectomised group at week 20. This is consistent with previous findings which 
found a significant reduction in the mineral-matrix ratio in normal vs. osteoporotic bone [17]. This data is 
supported by the significant reduction in hydroxyapatite measured in both the trabecular and compact bone from 
the ovariectomised animals. The FTIR mapping of the control samples was also indicative of a high mineral 
content. In contrast the ovariectomy group showed reduced absorption indicating a reduced mineral level. Those 
animals which started Aquamin treatment immediately after ovariectomy were found to have a mineral-matrix 
ratio significantly greater than the ovariectomy only group indicating a preservation of the healthy composition. 
Again this is borne out in the HA data from microCT analysis where HA content was higher in the Aquamin 
treated group than OVX.  FTIR maps of the Aquamin treated group were more akin to the control group 
signifying the preservation of mineral. The carbonate-phosphate ratio indicates the level of carbonate 
substitution in the HA crystal, a decrease in this ratio reflecting an increased phosphate content. However, no 
significant difference was seen in the carbonate-phosphate ratio in the current study.  
In tandem with the significant changes in composition measured using FTIR and microCT were changes in the 
tissue level mechanical properties as measured using nanoindentation. The biomechanical parameters of 
trabecular bone from slices adjacent to those used in FTIR revealed unsurprising parallels. The Young’s 
modulus of trabecular bone from ovariectomised animals was significantly less than the controls. This correlates 
with data from previous studies examining the tissue level mechanical properties of ovariectomised bone 
compared to healthy samples [16,26]. Trabeculae from animals who received Aquamin had a significantly 
higher modulus and hardness than from ovariectomised animals. While this effect has not been demonstrated 
previously, it is in keeping with the preservation of composition by Aquamin shown in the study.  
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The nanoindentation results did yield some interesting data in terms of the cortical bone. Material strength 
assessment showed that both modulus and hardness in the Aquamin delay group were significantly greater than 
the control group. Although not significant, both modulus and hardness were higher in the cortical shell of 
ovariectomised animals and the Aquamin treated group than of controls. Supporting this was the hydroxyapatite 
content which was not significantly different between the control and either Aquamin groups. Micro-CT data 
indicated a sustained loss of trabecular bone volume following ovariectomy over the 20 week study. However, 
when the trabecular thickness was examined it was found to decrease until week 8 at which point it began to 
increase again. This data supports the theory of bone compensation whereby new bone is laid down on surviving 
trabeculae to compensate for the loss of other trabeculae [27,28]. In addition to laying down new bone in 
trabeculae, new bone may also be laid down in the cortical shell [29]. However, as many studies have shown a 
thinning of the cortical shell this is probably not the case and the current study showed an overall reduction in 
the maximum load sustained by the tibial shaft from ovariectomised animals between weeks 2 and 20. It is 
possible that secondary mineralisation is increased in the cortical bone. In conjunction with the availability of 
Aquamin this could account for the higher tissue level mechanical values measured. Mechanical testing of the 
whole tibial shaft did go some way towards supporting this theory. The stiffness measured in the Aquamin 
group was significantly greater than the OVX. Although not significant, a higher maximum load was measured 
in the Aquamin (132 ± 13 N) and Aquamin delay (136 ± 12 N) than in the control (121 ± 10 N). It is not 
immediately clear what influence Aquamin in combination with ovariectomy had on compact bone and further 
investigation of this is warranted.  
To help with those assessments, a longer term study would advance our understanding of how Aquamin 
behaves. An extended duration would likely have yielded additional significant changes due to Aquamin and 
also the response to a delayed Aquamin therapy. Further study is also required to fully ascertain the timeframes 
involved for a delayed treatment regime to be effective. It would also be interesting to measure bone formation 
and resorption rates in further studies. This could be conducted by either looking at serum biomarkers or 
through the use of fluorochrome markers to determine where bone formation is taking place. Clinically, calcium 
is prescribed in combination with vitamin D. Therefore an assessment of the combined influence of Aquamin 
and vitamin D would be merited.  
Conclusion 
This study has demonstrated that providing calcium in the form of a seaweed derived mineral supplement, 
namely Aquamin, offers significant advantages over calcium carbonate. Trabecular architecture is significantly 
preserved when using Aquamin as compared to calcium carbonate. This is supported by a preservation of the 
mineral phase of bone which is mirrored by the improved material properties of the bone. Overall, this study 
supports the use of Aquamin as a supplement to aid in the prevention of bone loss in post-menopausal women.  
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Table 1: The Young’s Modulus and hardness measured in the cortical shell and in trabecular bone 
from the core and the edge of the proximal tibia at week 20.  
Location 
Modulus (GPa) 
Control OVX OVX + Aquamin 
OVX + Aquamin 
Delay 
Core 7.61 ± 3.67 
a 5.44 ± 2.53 a b * 5.99 ± 1.20 b 5.13 ± 0.97 * 
Edge 5.56 ± 3.87 
b 3.71 ± 1.94 5.48 ± 0.95 b # 3.91 ± 0.71 
Cortical Shell 3.35 ± 0.51 3.86 ± 2.55 4.10 ± 0.55 4.70 ± 0.67 ** 
Location 
Hardness (GPa) 
Control OVX OVX + Aquamin 
OVX + Aquamin 
Delay 
Core 0.43 ± 0.10 
a 0.37 ± 0.07 0.42 ± 0.08 b 0.29 ± 0.05 * & 
Edge 0.37 ± 0.08 
b # 0.28 ± 0.06 0.38 ± 0.07 b # % 0.24 ± 0.04 
Cortical Shell 0.24 ± 0.04 0.25 ± 0.03 0.27 ± 0.04 ^ 0.27 ± 0.04 ^ 
Mean ± standard deviation. Significant difference of p ≤ 0.05 between locations: a > edge, b > cortical 
shell. Between groups: * < control, # > OVX, ** > control, & < OVX + Aquamin, % > OVX + 
Aquamin delay, ^ > control.   
Table 2: Maximum load, maximum displacement and stiffness measured using three point bend 
testing of the tibia.  
Mechanical 
Property 
Group Week 0 Week 2 Week 20 
Maximum 
Load 
(N) 
Control 129.62 ± 2.02 128.03 ± 20.19 121.12 ± 10.20 
OVX - 141.80 ± 9.41 122.23 ± 12.10 * 
OVX + Aquamin - 132.26 ± 19.36 131.85 ± 13.96 
OVX + Aquamin 
Delay 
- - 136.80 ± 12.11 
Maximum 
Displacement 
(mm) 
Control 0.55 ± 0.14 0.54 ± 0.09 0.55 ± 0.13 
OVX - 0.53 ± 0.15 0.54 ± 0.14 
OVX + Aquamin - 0.54 ± 0.24 0.51 ± 0.2 
OVX + Aquamin 
Delay 
- - 0.47 ± 0.06 
Stiffness  
(N/mm) 
Control 244.39 ± 59.76 247.86 ± 72.58 292.93 ± 66.37 
OVX - 297.35 ± 128.59 257.95 ±  67.10 
OVX + Aquamin - 296.39 ± 140.21 368.25  ± 86.11
# 
OVX + Aquamin 
Delay 
- - 293.19 ± 51.24 
Significant difference of p ≤ 0.05: Within the OVX group, * > week 2. Between groups, # > OVX. 
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Fig 1: Representative (a) 3-dimensional microCT reconstructions of trabecular bone from the 
proximal tibia and (b) 2-dimensional slices through the midsection of the proximal tibia of rats at 
week 20. 
 
 
Fig 2: Percentage change in structural parameters in the metaphyseal proximal tibia for all groups 
over all time points. N = 6 per group (* indicates p < 0.05 and ** p <0.005 between control and OVX, 
# indicates p < 0.05 between OVX and OVX + Aquamin). 
 
17 
 
 
Fig 3: Hydroxyapatite content measured using microCT indicates a significant reduction in HA 
content in both trabecular and cortical bone following twenty weeks of ovariectomy. Aquamin 
administration prevented this loss of HA in both bone types and a significant preservation was also 
seen in the Aquamin delay group (* indicates p<0.05 between control, # indicates p<0.05 between 
OVX). 
 
 
Fig 4: (a) FTIR absorbance (left) and reflection (right) heat maps with white light image (centre) from 
a representative sample of each group at week 20. In the absorbance maps areas of red indicate 
increased absorbance (mineralisation) while in infra-red reflection maps, purple indicates increased 
mineralisation. (b) Typical absorbance spectrum of bone indicating peaks used to calculate 
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mineral/matrix ratio and carbonate/phosphate ratios. (c) The mineral/matrix ratio was significantly 
reduced following 20 weeks of estrogen deficiency (* p<0.05 relative to control). This loss of mineral 
was prevented by administering Aquamin from week 0 (# p<0.05 relative to OVX). (d) No significant 
changes were measured in the carbonate/phosphate ratio between groups.  
 
 
 
